CIBC Private Wealth Group LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1298088 ATLANTA, GA

Position in MRVI

as of Dec 31, 2025 · filed Feb 12, 2026 Compact

Position Value

$907,478

-$273,498 QoQ

Shares Held

279,224

-32.1% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Dec 31, 2025

CIBC Private Wealth Group LLC holds $101,906,850 across 130 Biotechnology names. MRVI ranks #8 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	200,425	$79,699,001
2	VRTX	Vertex Pharmaceuticals Inc / Ma	7,087	$3,212,962
3	AXSM	Axsome Therapeutics, Inc.	15,684	$2,864,525
4	LXRX	Lexicon Pharmaceuticals, Inc.	1,950,000	$2,242,500
5	ASND	Ascendis Pharma A/S	9,382	$2,000,617
6	REGN	Regeneron Pharmaceuticals, Inc.	1,943	$1,499,743
7	PGEN	Precigen, Inc.	274,712	$1,148,296
8	MRVI	Maravai Lifesciences Holdings, Inc. This page	279,224	$907,478

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$907,478	279,224	-32.1%	Shares	Sole	2026-02-12
2025-09-30	$1,180,976	411,490	0.0%	Shares	Sole	2025-11-24
2025-06-30	$991,690	411,490	-0.0%	Shares	Sole	2025-08-12
2025-03-31	$909,666	411,614	+60879.9%	Shares	Sole	2025-05-14
2024-12-31	$3,678	675	0.0%	Shares	Sole	2025-02-12
2024-09-30	$5,609	675	-99.2%	Shares	Sole	2024-11-13
2021-06-30	$3,721,982	89,192	+14.8%	Shares	Defined	2021-08-16
2021-03-31	$2,769,584	77,710	—	Shares	Defined	2021-05-12
No filing history on record for this holder in this stock.